James L Weaver

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Topics

Molecular Dynamics Simulations

Respiratory Syndrome Coronavirus

Top Venues

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammadreza Samieegohar, James L Weaver, Kristina E Howard, Anik Chaturbedi, John Mann, Xiaomei Han, Joel Zirkle, Ghazal Arabidarrehdor, Rodney Rouse, Jeffry Florian, David G Strauss, Zhihua Li
Calibration and Validation of a Mechanistic COVID-19 Model for Translational Quantitative Systems Pharmacology - A Proof-of-Concept Model Development for Remdesivir. Clinical pharmacology and therapeutics 112 (4) (2022)
Paula L Hyland, Lakshmi Manasa S Chekka, Deepti P Samarth, Barry A Rosenzweig, Erica Decker, Esraa G Mohamed, Yan Guo, Murali K Matta, Qin Sun, William Wheeler, Carlos Sanabria, James L Weaver, Sarah J Schrieber, Jeffry Florian, Yow-Ming C Wang, David G Strauss
Evaluating the Utility of Proteomics for the Identification of Circulating Pharmacodynamic Biomarkers of IFNβ-1a Biologics. Clinical pharmacology and therapeutics (2022)
Victoria Gershuny, Qin Sun, Sarah J Schrieber, Murali K Matta, James L Weaver, Ping Ji, Morasa Sheikhy, Cheng-Hui Hsiao, Giri Vegesna, Aanchal Shah, Kristin Prentice, Jennifer Deering, Yow-Ming C Wang, David G Strauss, Jeffry Florian
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (II) A Randomized Trial with IL-5 Antagonists. Clinical pharmacology and therapeutics (2022)